Matthew Bidwell Goetz

Matthew Bidwell Goetz

Auto-generated profile, based on publicly available information

Matthew Bidwell Goetz

VA Greater Los Angeles Healthcare System

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2013 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
MFMatthew S. Freiberg
Matthew S. Freiberg
CCChung-Chou H. Chang
Chung-Chou H. Chang
LKLewis H. Kuller
Lewis H. Kuller
MSMelissa Skanderson
Melissa Skanderson
ELElliott Lowy
Elliott Lowy
AJAmy C. Justice
Amy C. Justice
With the success of antiretroviral therapy (ART), people infected with human immunodeficiency virus (HIV) are now living longer and are at risk for heart disease. Determining whether HIV-positive people have an increased risk of acute myocardial infarction (AMI) compared with uninfected people is a central question1 with important clinical implications. Although prior studies2-6 have reported an association between HIV and AMI, the results may have been confounded by the choice of reference group, the lack of adjudicated AMI outcomes, a lack of fatal events, and/or missing risk factor data. We investigated whether HIV is associated with an increased risk of AMI after adjustment for all standard Framingham risk factors among a large cohort of HIV-positive and demographically and behaviorally similar (ie, similar prevalence of smoking, alcohol, and cocaine use) uninfected veterans in care.

1 February 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
KCKristina Crothers
Kristina Crothers
LHLaurence Huang
Laurence Huang
JGJoseph L. Goulet
Joseph L. Goulet
MGMatthew Bidwell Goetz
Matthew Bidwell Goetz
SBSheldon T. Brown
Sheldon T. Brown
AJAmy C. Justice
Amy C. Justice
Rationale: In aging HIV-infected populations comorbid diseases are important determinants of morbidity and mortality. Pulmonary diseases have not been systematically assessed in the combination antiretroviral therapy (ART) era. Objectives: To determine the incidence of pulmonary diseases in HIV-infected persons compared with HIV-uninfected persons. Methods: We analyzed data from the Veterans Aging Cohort Study Virtual Cohort, consisting of 33,420 HIV-infected veterans and 66,840 age, sex, race and ethnicity, and site-matched HIV-uninfected veterans. Using Poisson regression, incidence rates and adjusted incidence rate ratios were calculated to determine the association of HIV with pulmonary disease. The Virtual Cohort was merged with the 1999 Veterans Large Health Survey to adjust for self-reported smoking in a nested sample (14%). Measurements and Main Results: Incident chronic obstructive pulmonary disease, lung cancer, pulmonary hypertension, and pulmonary fibrosis, as well as pulmonary infections, were significantly more likely among HIV-infected patients compared with uninfected patients in adjusted analyses, although rates of asthma did not differ by HIV status. Bacterial pneumonia and chronic obstructive pulmonary disease were the two most common incident pulmonary diseases, whereas opportunistic pneumonias were less common. Absolute rates of most pulmonary diseases increased with age, although the relative differences between those with and without HIV infection were greatest in younger persons. Chronic obstructive pulmonary disease and asthma, as well as pulmonary infections, were less likely in those with lower HIV RNA levels and use of ART at baseline. Conclusions: Pulmonary diseases among HIV-infected patients receiving care within the Veterans Affairs Healthcare System in the combination ART era reflect a substantial burden of non–AIDS-defining and chronic conditions, many of which are associated with aging.

24 December 2002 in Neurology
Verified
Journal Article
Closed access
PDF file
CHC.H. Hinkin
C.H. Hinkin
SCS.A. Castellon
S.A. Castellon
RDR.S. Durvasula
R.S. Durvasula
DHD.J. Hardy
D.J. Hardy
MLM.N. Lam
M.N. Lam
MSM. Stefaniak
M. Stefaniak
Background: Although the use of highly active antiretroviral therapy in the treatment of HIV infection has led to considerable improvement in morbidity and mortality, unless patients are adherent to their drug regimen (i.e., at least 90 to 95% of doses taken), viral replication may ensue and drug-resistant strains of the virus may emerge. Methods: The authors studied the extent to which neuropsychological compromise and medication regimen complexity are predictive of poor adherence in a convenience sample of 137 HIV-infected adults. Medication adherence was tracked through the use of electronic monitoring technology (MEMS caps). Results: Two-way analysis of variance revealed that neurocognitive compromise as well as complex medication regimens were associated with significantly lower adherence rates. Cognitively compromised participants on more complex regimens had the greatest difficulty with adherence. Deficits in executive function, memory, and attention were associated with poor adherence. Logistic regression analysis demonstrated that neuropsychological compromise was associated with a 2.3 times greater risk of adherence failure. Older age (>50 years) was also found to be associated with significantly better adherence. Conclusions: HIV-infected adults with significant neurocognitive compromise are at risk for poor medication adherence, particularly if they have been prescribed a complex dosing regimen. As such, simpler dosing schedules for more cognitively impaired patients might improve adherence.

1 April 2011 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
FKFasiha Kanwal
Fasiha Kanwal
THTuyen Hoang
Tuyen Hoang
JKJennifer R. Kramer
Jennifer R. Kramer
SASteven M. Asch
Steven M. Asch
MGMatthew Bidwell Goetz
Matthew Bidwell Goetz
HEHashem B. El–Serag
Hashem B. El–Serag

1 August 2006 in Medical Care
Verified
Journal Article
Closed access
AJAmy C. Justice
Amy C. Justice
EDElizabeth Mba Dombrowski
Elizabeth Mba Dombrowski
JCJoseph Conigliaro
Joseph Conigliaro
SFShawn L. Fultz
Shawn L. Fultz
DGDeborah Ma Gibson
Deborah Ma Gibson
KBKendall Bryant
Kendall Bryant
Background: The Veterans Aging Cohort Study (VACS) is a study of human immunodeficiency virus (HIV) infected and uninfected patients seen in infectious disease and general medical clinics. VACS includes the earlier 3 and 5 site studies (VACS 3 and VACS 5) as well as the ongoing 8 site study. Objectives: We sought to provide background and context for analyses based upon VACS data, including study design and rationale as well as its basic protocol and the baseline characteristics of the enrolled sample. Research Design: We undertook a prospectively consented multisite observational study of veterans in care with and without HIV infection. Measures: Data were derived from patient and provider self report, telephone interviews, blood and DNA samples, focus groups, and full access to the national VA “paperless” electronic medical record system. Results: More than 7200 veterans have been enrolled in at least one of the studies. The 8 site study (VACS) has enrolled 2979 HIV-infected and 3019 HIV-uninfected age–race–site matched comparators and has achieved stratified enrollment targets for race/ethnicity and age and 99% of its total target enrollment as of October 30, 2005. Participants in VACS are similar to other veterans receiving care within the VA. VACS participants are older and more predominantly black than those reported by the Centers for Disease Control. Conclusions: VACS has assembled a rich, in-depth, and representative sample of veterans in care with and without HIV infection to conduct longitudinal analyses of questions concerning the association between alcohol use and related comorbid and AIDS-defining conditions.

19 June 2009 in AIDS
Verified
Journal Article
Closed access
ABAdeel A Butt
Adeel A Butt
KMKathleen McGinnis
Kathleen McGinnis
MRMaria C Rodriguez-Barradas
Maria C Rodriguez-Barradas
SCStephen Crystal
Stephen Crystal
MSMichael Simberkoff
Michael Simberkoff
AJAmy C Justice
Amy C Justice
Background: The influence of HIV infection on the risk of diabetes is unclear. We determined the association and predictors of prevalent diabetes mellitus in HIV infected and uninfected veterans. Methods: We determined baseline prevalence and risk factors for diabetes between HIV infected and uninfected veterans in the Veterans Aging Cohort Study. Logistic regression was used to determine the odds of diabetes in HIV infected and uninfected persons. Results: We studied 3227 HIV-infected and 3240 HIV-uninfected individuals. HIV-infected individuals were younger, more likely to be black males, have HCV coinfection and a lower BMI. HIV-infected individuals had a lower prevalence of diabetes at baseline (14.9 vs. 21.4%, P < 0.0001). After adjustment for known risk factors, HIV-infected individuals had a lower risk of diabetes (odds ratio = 0.84, 95% confidence interval = 0.72–0.97). Increasing age, male sex, minority race, and BMI were associated with an increased risk. The odds ratio for diabetes associated with increasing age, minority race and BMI were greater among HIV-infected veterans. HCV coinfection and nucleoside and nonnucleoside reverse transcriptase inhibitor therapy were associated with a higher risk of diabetes in HIV-infected veterans. Conclusion: Although HIV infection itself is not associated with increased risk of diabetes, increasing age; HCV coinfection and BMI have a more profound effect upon the risk of diabetes among HIV-infected persons. Further, long-term ARV treatment also increases risk. Future studies will need to determine whether incidence of diabetes mellitus differs by HIV status.